Abstract: The present invention is directed to imidazopyridin-2-one derivatives which are potentiators of metabotropic glutamate receptors, particularly the mGluR2 receptor, and which are useful in the treatment or prevention of neurological and psychiatric disorders associated with glutamate dysfunction and diseases in which metabotropic glutamate receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which metabotropic glutamate receptors are involved.

Abstract: A holding mechanism of a display device includes a first arm, a second arm and a damper. The first arm and the second arm hold the display device in such a manner that the display device is capable of being displaced between a first disposition in which a lower edge portion of the display device is away from a placing face with a display screen facing to a front and a. second disposition in which the lower edge portion is in contact with the placing face with the display screen facing more upward than in the first disposition. The damper applies, to the first arm, a force that buffers a force by which the display device is liable to displacement from the first disposition to the second disposition due to self-weight.

Abstract: A photoelectric conversion element includes an optically transparent support, a porous semiconductor layer containing fine semiconductor particles and a photosensitizer, a conductive layer, and a counter electrode provided in that order, each of the porous semiconductor layer and the conductive layer contains a carrier-transport material. The porous semiconductor layer includes at least two layers each containing fine semiconductor particles having different particle sizes. The fine semiconductor particles contained in a layer of the layers located closest to the counter electrode, the layers constituting the porous semiconductor layer, have an average particle size of 380 nm or less.

Abstract: The instant invention provides compounds of formula I which are JAK3 inhibitors. Specifically, the compounds of formula I are pyrrolo[2,3-d]pyrimidine derivative compounds. The instant invention also provides methods of treating JAK-mediated diseases such as rheumatoid arthritis, asthma, COPD and cancer, by administering the pyrrolo[2,3-d]pyrimidine-derivative compounds of formula I.

Abstract: A level shift circuit of an embodiment includes first and second MOSFETs using signals with phases same as and opposite to the phase of an input signal as gate inputs; first and second resistance elements, each having one end connected to a shift level power terminal that supplies high-level output voltage of a level-shifted output signal, and each having the other end connected to a corresponding drain of the first and second MOSFETs; a comparator having a pair of differential input terminals, individually connected to respective drains of the first and second MOSFETs; and a current control circuit that controls an amount of first current flowing through the first MOSFET via the first resistance element and an amount of second current flowing through the second MOSFET via the second resistance element in synchronization with a rising and a falling of a signal level of the input signal.

Abstract: A wireless communication apparatus includes: a receiving unit that receives a signal indicating a frequency band having the highest priority of selection among a plurality of frequency bands; and a transmitting unit that transmits data in parallel, using the frequency band having the highest priority of selection and a frequency band having a priority of selection lower than that of the frequency band having the highest priority of selection.

Abstract: This inventions relates to compounds having the structure Formula I and pharmaceutically acceptable salts thereof which are soluble guanylate cyclase activators. The compounds are useful for treatment or prevention of cardiovascular diseases, endothelial dysfunction, diastolic dysfunction, atherosclerosis, hypertension, pulmonary hypertension, angina pectoris, thromboses, restenosis, myocardial infarction, strokes, cardiac insufficiency, pulmonary hypertonia, erectile dysfunction, asthma bronchiale, chronic kidney insufficiency, diabetes, or cirrhosis of the liver.

Abstract: Disclosed is a light emitting element, which emits light with small power consumption and high luminance. The light emitting element has: a IV semiconductor substrate; two or more core multi-shell nanowires disposed on the IV semiconductor substrate; a first electrode connected to the IV semiconductor substrate; and a second electrode, which covers the side surfaces of the core multi-shell nanowires, and which is connected to the side surfaces of the core multi-shell nanowires. Each of the core multi-shell nanowires has: a center nanowire composed of a first conductivity type III-V compound semiconductor; a first barrier layer composed of the first conductivity type III-V compound semiconductor; a quantum well layer composed of a III-V compound semiconductor; a second barrier layer composed of a second conductivity type III-V compound semiconductor; and a capping layer composed of a second conductivity type III-V compound semiconductor.

Abstract: An image reader is provided, in its housing, with a first scanning unit made up of an LED array of a plurality of LED elements that are arranged in a row in the horizontal scanning direction and that emit light to a document. An air intake port and an air exhaust port are disposed on the housing of the image reader. An imaginary line of an air flow path coupling the air intake port and the air exhaust port to one another is configured to pass adjacent a center of the LED array of the first scanning unit in the horizontal scanning direction with the first scanning unit stopped at a reading position of the document transferred by a document transfer device.

Abstract: In an active matrix display apparatus including: pixels provided in a matrix pattern, the pixels each including a memory circuit which retains data while refreshing the data, a data signal electric potential which is supplied from a source line in a period t1 and written to a node which is connected to a liquid capacitor is higher than a data electric potential of the node, the data electric potential being obtained in a period t14 after a refresh operation of the memory circuit.

Abstract: Novel crystalline forms of (2R,3S,5R)-2-(2,5-Difluorophenyl)-5-[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl]tetrahydro-2H-pyran-3-amine are potent inhibitors of dipeptidyl peptidase-IV and are useful for the treatment of non-insulin dependent (Type 2) diabetes mellitus. The invention also relates to pharmaceutical compositions containing these novel forms, processes to prepare these forms and their pharmaceutical compositions as well as uses thereof for the treatment of Type 2 diabetes.

Abstract: Novel compounds of the structural formula (I) are activators of AMP-protein kinase and are useful in the treatment, prevention and suppression of diseases mediated by the AMPK-activated protein kinase. The compounds of the present invention are useful in the treatment of Type 2 diabetes, hyperglycemia, metabolic syndrome, obesity, hypercholesterolemia, and hypertension.

Abstract: A measuring part 67 measures the potential of a collecting electrode 66 having collected positive and negative ions respectively generated by ion generating parts 61 of ion generators 6a and 6b and ion generating parts 62 of ion generators 6c and 6d. In the judgment of the presence or absence of ions, the ion generators 6a and 6b and the ion generators 6c and 6d are alternately turned ON/OFF. In ion judgment 1, ON/OFF is performed 6 times with a period of 10 seconds. In ion judgment 2, ON/OFF is performed 10 times with a period of 1 second. Then, when the difference (the amount of change) between the maximum value and the minimum value of the output voltage of the measuring part 67 is greater than a given threshold value, the presence of ions is concluded respectively.

Abstract: The disclosed image enlargement device is provided with: an image enlargement filter (1) that enlarges an input image, generating a first enlarged image; a first wavelet transformation unit (2) that performs a wavelet transformation on the first enlarged image; a second wavelet transformation unit (3) that performs a wavelet transformation on the first enlarged image; and an accentuation processing unit (6, 7, 8, 10) that performs an accentuation process using a first edge signal (EDGE_CDF9/7), generated from the output of the first wavelet transformation unit, and a second edge signal (EDGE_Harr), generated from the output of the second wavelet transformation unit. The first wavelet transformation unit and the second wavelet transformation unit perform different wavelet transformations.

Abstract: The present invention is directed to fused heterocyclic indane carboxamide derivatives which are antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.

Abstract: In one embodiment of the present invention, a display controller includes a stable pixel writing period in one horizontal period in a display device, the stable pixel writing period being a period during which a voltage outputted from a gate driver is at a high level. The display controller also includes a first stable pixel writing period determination circuit which determines, by using a reference signal independent from the frame rate in the display device, the stable pixel writing period during which the voltage is at the high level. Thus, the display controller can be provided in which, regardless of whether and how the frame rate is changed, the stable pixel writing period can be of a target length.

Abstract: A liquid crystal display device (10) includes: LEDs (17); a liquid crystal panel (11); a light guide plate (16); an exterior member that constitutes the exterior of the liquid crystal display device (10), the exterior member including a frame (13) and a chassis (14) that hold the liquid crystal panel (11) and the light guide plate (16) by sandwiching these from the display surface (11c) side and the opposite side thereto, while housing the LEDs (17) between the frame (13) and the chassis (14); a screw member (SM) that affixes the frame (13) and the chassis (14) to each other by being disposed in an outer edge portion that surrounds the liquid crystal panel (11); wiring members (28) that are connected to the LEDs (17); and wiring passages (30) through which the wiring members (28) pass, the wiring passages being formed in the inner surfaces of the side walls (13b), which is the outer edge portions of the frame (13), the wiring passages being positioned adjacent to the screw member (SM) in the direction in whic

Abstract: A backlight unit 12 according to the present invention includes an LED 17, an LED board 18, a connector 25, a chassis-side reflection sheet 22, and a support 26. The LED 17 is a light source. The LED 17 is mounted on the LED board 18. The connector 25 is a mounted component mounted on a mounting surface 18a of the LED board 18 on which the LED 17 is mounted. The chassis-side reflection sheet 22 is a reflection sheet 21 configured to reflect light and arranged on a side on which the mounting surface 18a is arranged. The mounting surface 18a is the surface on which the LED 17 and the connector 25 are mounted. The support 26 holds the chassis-side reflection sheet 22 away from the mounting surface 18a of the LED board 18.

Abstract: Based on a sounding reference signal, a base station apparatus performs efficient scheduling. The base station apparatus includes information for requesting the transmission of the sounding reference signal in a first downlink control information format or a second downlink control information format, and transmits the information to the mobile station apparatus, the mobile station apparatus transmits, based on detection of the information, the sounding reference signal to the base station apparatus, and a first parameter used for the transmission of the sounding reference signal based on the detection of the information included in the first downlink control information format and a second parameter used for the transmission of the sounding reference signal based on the detection of the information included in the second downlink control information format are individually set by a signal of a higher layer transmitted from the base station apparatus.

Abstract: A touch panel includes: an infrared light transmitting material through which infrared light is transmitted and which has a surface as a touch surface (20) touched by a detection subject; area sensors (3) including photo sensor elements (4) below a touch region, which is touched by the detection subject, of the infrared light transmitting material; and infrared light sources (1) provided outside the touch region, the infrared light sources (1) emitting infrared light along said surface of the infrared light transmitting material such that an entire circumference of the detection subject touching the touch surface (20) is irradiated with the infrared light, the touch panel detecting a position touched by the detection subject so that the photo sensor element (4) receives, among infrared light emitted by the infrared light sources (1) along said surface, infrared light reflected by the detection subject and transmitted through the infrared light transmitting material.